sarcoma, or osteosarcoma. ## Results . Between 1987-1991, 81 patients were entered; 69 patients were eligible.
Epidemiology of osteosarcoma and Ewing's sarcoma in childhood : A study of 305 cases by the Children's Cancer Group
β Scribed by Jonathan D. Buckley; Thomas W. Pendergrass; Constance M. Buckley; Douglas J. Pritchard; Mark E. Nesbit; Arthur J. Provisor; Leslie L. Robison
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 84 KB
- Volume
- 83
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
Background:
The children's cancer group conducted a case-control study to determine the role of a broad range of environmental and familial factors in the etiology of ewing's sarcoma and osteosarcoma in children. these factors included radiation exposure and, for children with osteosarcoma, parental exposure to beryllium.
Methods:
The parents of 152 children with osteosarcoma and 153 children with ewing's sarcoma were interviewed by telephone. controls were obtained by random digit dialing and were matched to cases by age and race.
Results:
Female osteosarcoma patients had earlier onset of breast development (age 11.4 vs. 11.8 years, p=0.03) and menarche (age 12.1 vs. 12.5 years, p=0.002) but no significant differences in growth, whereas male osteosarcoma patients were similar in age at the onset of secondary sexual characteristics but reported significantly less weight gain during their growth spurt (6.6 vs. 11.7 kg, p=0.003). for children with ewing's sarcoma, the growth spurt began earlier (age 12.1 vs. 12.7 years, p=0.12) and resulted in less weight and height gain (5.2 vs. 9.7 kg, p=0.002, and 10.2 vs. 12.7 cm, p=0.02, respectively) for males, but no differences were observed among females. for factors not related to growth and development (including a wide range of occupational, medical, and household exposures), there was little evidence of an etiologic role with respect to either tumor type.
Conclusions:
Differences between cases and controls with respect to growth and development showed no consistent pattern. this study did not identify any important risk factors for either type of childhood bone tumor.
π SIMILAR VOLUMES
promising salvage regimen. Continued accrual of patients and increased duration of follow-up has resulted in substantial experience with VETOPEC.
Background. Maintenance of second remission of childhood acute lymphoblastic leukemia (ALL) with intensive chemotherapy is often unsuccessful. The major cause of treatment failure is relapse. Materials and Methods. Of 96 children with ALL who relapsed in the marrow while on or within 1 year of comp
## Background: The authors have determined the prognostic significance of cytogenetically detectable 12p abnormalities, which are frequent in children with acute lymphoblastic leukemia (all), in a large cohort of patients treated on risk-adjusted protocols of the children's cancer group (ccg). ##
## BACKGROUND. Carboplatin is an analogue of cisplatin with less nonhematologic toxicity